$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
达洛鲁胺我国是否批准上市了?达洛鲁胺进2021医保了吗?
2025-10-19 11:44:20
Check Details
靶向药达洛鲁胺能显著改善非转移性前列腺癌患者的生存率
2025-10-19 11:44:20
Check Details
【前列腺癌新药】达洛鲁胺在国内获批,更安全,更高效
2025-10-19 11:44:20
Check Details
安森珂(阿帕鲁胺)是什么药?2分钟带你看完安森珂药品说明书
2025-10-19 11:44:20
Check Details
前列腺癌新药安森珂(阿帕他胺)效果如何?哪些人适合用安森珂?
2025-10-19 11:44:20
Check Details
安森珂治疗什么?厂家是哪个?安森珂中国上市多少钱一盒?
2025-10-19 11:44:20
Check Details
新福利:安森珂的mHSPC适应症获药监局“优先审批”
2025-10-19 11:44:20
Check Details
泽珂是哪个厂家生产的?泽珂哪个国家的进口药?
2025-10-19 11:44:20
Check Details
泽珂在中国哪里可以买到?
2025-10-19 11:44:20
Check Details
泽珂纳入医保后需要自费掏多少钱?泽珂报销比例介绍!
2025-10-19 11:44:20
Check Details
恩杂鲁胺2021纳入医保了吗?恩杂鲁胺国内价格多少?
2025-10-19 11:44:20
Check Details
恩杂鲁胺多少钱一瓶,恩杂鲁胺最新价格
2025-10-19 11:44:20
Check Details
1
2
...
7604
7605
7606
7607
7608
7609
7610
...
10214
10215
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
2
Niraparib: A PARP Inhibitor for Ovarian Cancer Maintenance Therapy
3
Abiraterone Acetate: CYP17 Inhibitor for Advanced Prostate Cancer
4
Plerixafor: Mobilizing Hematopoietic Stem Cells for Autologous Transplantation
5
Brensoctib: Managing Side Effects of the Novel DPP-1 Inhibitor for Bronchiectasis
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Trelagliptin: The First Once-Weekly DPP-4 Inhibitor Revolutionizing Type 2 Diabetes Care
9
Adagrasib Medication Management Guide for Special Populations
10
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
11
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
12
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment